Cellular processing of a ricin-antibody conjugate: a kinetic analysis of the rate-limiting stepMARSH, J. W.The Journal of biological chemistry (Print). 1989, Vol 264, Num 18, pp 10405-10410, issn 0021-9258, 6 p.Article

Therapeutic targets and recent advances in protein immunotoxinsMADHUMATHI, J; VERMA, Rama S.Current opinion in microbiology. 2012, Vol 15, Num 3, pp 300-309, issn 1369-5274, 10 p.Article

Mab-zap : A tool for evaluating antibody efficacy for use in an immunotoxinKOHLS, M. D; LAPPI, D. A.BioTechniques. 2000, Vol 28, Num 1, pp 162-165, issn 0736-6205Article

Immunotoxins : will their clinical promise be fulfilled ?VALLERA, D. A.Blood. 1994, Vol 83, Num 2, pp 309-317, issn 0006-4971Article

Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patientsDURRANT, L. G; BYERS, V. S; SCANNON, P. J et al.Clinical and experimental immunology (Print). 1989, Vol 75, Num 2, pp 258-264, issn 0009-9104Article

Cytotoxic Activity of Immunotoxin SS1 P Is Modulated by TACE-Dependent Mesothelin SheddingYUJIAN ZHANG; CHERTOV, Oleg; JINGLI ZHANG et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5915-5922, issn 0008-5472, 8 p.Article

Antibody toxin conjugates: a perspectiveBLAKEY, D. C; WAWRZYNCZAK, E. J; WALLACE, P. M et al.Progress in allergy. 1988, Vol 45, pp 50-90, issn 0079-6034Article

Immunotoxin therapy of lymphoid neoplasmsGROSSBARD, M. L; NADLER, L. M.Seminars in hematology. 1994, Vol 31, Num 1, pp 88-97, issn 0037-1963Article

Immunotoxins to human small-cell lung cancerWAWRZYNCZAK, E. J; DERBYSHIRE, E. J.Cell biophysics. 1992, Vol 21, Num 1-3, pp 13-23, issn 0163-4992Conference Paper

Purification of ricin A₁, A₂, and B chains and characterization of their toxicityFULTON, R. J; BLAKEY, D. C; KNOWLES, P. P et al.The Journal of biological chemistry (Print). 1986, Vol 261, Num 12, pp 5314-5319, issn 0021-9258Article

HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicityBANG, Sookhee; NAGATA, Satoshi; ONDA, Masanori et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1545-1550, issn 1078-0432, 6 p.Article

Recombinant immunotoxins for the treatment of cancerFITZGERALD, D; PASTAN, I.Journal of controlled release. 1996, Vol 39, Num 2-3, pp 261-266, issn 0168-3659, 5 p.Conference Paper

Monensin enhances the cytotoxic effect of antitransferrin receptor immunotoxin on cultured RPE cellsHANDA, J. T; HOUSTON, L. L; JAFFE, G. J et al.Current eye research (Print). 1993, Vol 12, Num 1, pp 45-53, issn 0271-3683Article

Recombinant toxins containing the variable domains of the anti-tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemiaKREITMAN, R. J; CHAUDHARY, V. K; KOZAK, R. W et al.Blood. 1992, Vol 80, Num 9, pp 2344-2352, issn 0006-4971Article

Folding and aggregation of a multi-domain engineered immunotoxinMAURER, Ronald W; HUNTER, Alan K; XIANGYANG WANG et al.Biochemical engineering journal. 2013, Vol 81, pp 8-14, issn 1369-703X, 7 p.Article

Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug ConjugatesFITZGERALD, David J; WAYNE, Alan S; KREITMAN, Robert J et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 20, pp 6300-6309, issn 0008-5472, 10 p.Article

Increasing secretion of a bivalent anti-T-cell immunotoxin by Pichia pastorisJUNG HEE WOO; YUAN YI LIU; STAVROU, Scott et al.Applied and environmental microbiology (Print). 2004, Vol 70, Num 6, pp 3370-3376, issn 0099-2240, 7 p.Article

Cryopreservation of human bone marrow after purging T-cells or tumor cellsZHONG-XING ZHANG; YUAN-JI XU; YUEN CHEN et al.Cryobiology (Print). 1994, Vol 31, Num 5, pp 478-482, issn 0011-2240Article

Cytotoxicity against human peripheral blood mononuclear cells and T cell lines mediated by anti-T cell immunotoxins in the absence of added potentiatorFISHWILD, D. M; STASKAWICZ, M. O; WU, H.-M et al.Clinical and experimental immunology (Print). 1991, Vol 86, Num 3, pp 506-513, issn 0009-9104Article

Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cellsWARGALLA, U. C; REISFELD, R. A.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 13, pp 5146-5150, issn 0027-8424Article

Treatment of murine EL4 leukemia in ascitic from with anti-Thy 1.2 specific immunotoxinsMARCHES, R; MOTA, G; MARGINEANU, M et al.Neoplasma. 1990, Vol 37, Num 5, pp 573-578, issn 0028-2685Article

Predictors of complete responses with denileukin diftitox in cutaneous T-cell lymphomaFOSS, Francine; DUVIC, Madeleine; OLSEN, Elise A et al.American journal of hematology. 2011, Vol 86, Num 7, pp 627-630, issn 0361-8609, 4 p.Article

Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapyMATHEW, Mrudula; VERMA, Rama S.Cancer science. 2009, Vol 100, Num 8, pp 1359-1365, issn 1347-9032, 7 p.Article

Recombinant immunotoxins for patients with hematologic malignanciesKREITMAN, Robert J.Recent research developments in bioconjugate chemistry (Volume 2 (2005)). 2005, pp 55-83, isbn 81-7895-168-1, 29 p.Book Chapter

Immunotoxins against cancerBRINKMANN, U; PASTAN, I.Biochimica et biophysica acta, CR. Reviews on cancer. 1994, Vol 1198, Num 1, pp 27-45, issn 0304-419XArticle